The Glutaminase-1 Inhibitor [<sup<11</sup<C-carbony]BPTES: Synthesis and Positron Emission Tomography Study in Mice
Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) is a selective inhibitor of glutaminase-1 (GLS1), consequently inhibiting glutaminolysis. BPTES is known for its potent antitumor activity and plays a significant role in senescent cell removal. In this study, we synthesized [<s...
Ausführliche Beschreibung
Autor*in: |
Yiding Zhang [verfasserIn] Katsushi Kumata [verfasserIn] Lin Xie [verfasserIn] Yusuke Kurihara [verfasserIn] Masanao Ogawa [verfasserIn] Tomomi Kokufuta [verfasserIn] Nobuki Nengaki [verfasserIn] Ming-Rong Zhang [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2023 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Pharmaceuticals - MDPI AG, 2005, 16(2023), 7, p 963 |
---|---|
Übergeordnetes Werk: |
volume:16 ; year:2023 ; number:7, p 963 |
Links: |
---|
DOI / URN: |
10.3390/ph16070963 |
---|
Katalog-ID: |
DOAJ09384431X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ09384431X | ||
003 | DE-627 | ||
005 | 20240413021510.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240413s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/ph16070963 |2 doi | |
035 | |a (DE-627)DOAJ09384431X | ||
035 | |a (DE-599)DOAJ19e9d20f8c2740e48bc14481b8ce8245 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RS1-441 | |
100 | 0 | |a Yiding Zhang |e verfasserin |4 aut | |
245 | 1 | 4 | |a The Glutaminase-1 Inhibitor [<sup<11</sup<C-carbony]BPTES: Synthesis and Positron Emission Tomography Study in Mice |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) is a selective inhibitor of glutaminase-1 (GLS1), consequently inhibiting glutaminolysis. BPTES is known for its potent antitumor activity and plays a significant role in senescent cell removal. In this study, we synthesized [<sup<11</sup<C-carbonyl]BPTES ([<sup<11</sup<C]BPTES) as a positron emission tomography (PET) probe for the first time and assessed its biodistribution in mice using PET. [<sup<11</sup<C]BPTES was synthesized by the reaction of an amine precursor () with [<sup<11</sup<C-carbonyl]phenylacetyl acid anhydride ([<sup<11</sup<C]<b<2</b<), which was prepared from [<sup<11</sup<C]CO<sub<2</sub< and benzyl magnesium chloride, followed by in situ treatment with isobutyl chloroformate. The decay-corrected isolated radiochemical yield of [<sup<11</sup<C]BPTES was 9.5% (based on [<sup<11</sup<C]CO<sub<2</sub<) during a synthesis time of 40 min. A PET study with [<sup<11</sup<C]BPTES showed high uptake levels of radioactivity in the liver, kidney, and small intestine of mice. | ||
650 | 4 | |a [<sup<11</sup<C-carbonyl]BPTES | |
650 | 4 | |a PET | |
650 | 4 | |a glutaminase-1 (GLS1) | |
650 | 4 | |a glutaminase-1 inhibitor | |
650 | 4 | |a senescence | |
650 | 4 | |a [<sup<11</sup<C]acylation | |
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
653 | 0 | |a Pharmacy and materia medica | |
700 | 0 | |a Katsushi Kumata |e verfasserin |4 aut | |
700 | 0 | |a Lin Xie |e verfasserin |4 aut | |
700 | 0 | |a Yusuke Kurihara |e verfasserin |4 aut | |
700 | 0 | |a Masanao Ogawa |e verfasserin |4 aut | |
700 | 0 | |a Tomomi Kokufuta |e verfasserin |4 aut | |
700 | 0 | |a Nobuki Nengaki |e verfasserin |4 aut | |
700 | 0 | |a Ming-Rong Zhang |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Pharmaceuticals |d MDPI AG, 2005 |g 16(2023), 7, p 963 |w (DE-627)491437528 |w (DE-600)2193542-7 |x 14248247 |7 nnns |
773 | 1 | 8 | |g volume:16 |g year:2023 |g number:7, p 963 |
856 | 4 | 0 | |u https://doi.org/10.3390/ph16070963 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/19e9d20f8c2740e48bc14481b8ce8245 |z kostenfrei |
856 | 4 | 0 | |u https://www.mdpi.com/1424-8247/16/7/963 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1424-8247 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2009 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2055 | ||
912 | |a GBV_ILN_2111 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 16 |j 2023 |e 7, p 963 |
author_variant |
y z yz k k kk l x lx y k yk m o mo t k tk n n nn m r z mrz |
---|---|
matchkey_str |
article:14248247:2023----::hguaiaeihbtru1spcroypesnhssnpstoei |
hierarchy_sort_str |
2023 |
callnumber-subject-code |
RS |
publishDate |
2023 |
allfields |
10.3390/ph16070963 doi (DE-627)DOAJ09384431X (DE-599)DOAJ19e9d20f8c2740e48bc14481b8ce8245 DE-627 ger DE-627 rakwb eng RS1-441 Yiding Zhang verfasserin aut The Glutaminase-1 Inhibitor [<sup<11</sup<C-carbony]BPTES: Synthesis and Positron Emission Tomography Study in Mice 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) is a selective inhibitor of glutaminase-1 (GLS1), consequently inhibiting glutaminolysis. BPTES is known for its potent antitumor activity and plays a significant role in senescent cell removal. In this study, we synthesized [<sup<11</sup<C-carbonyl]BPTES ([<sup<11</sup<C]BPTES) as a positron emission tomography (PET) probe for the first time and assessed its biodistribution in mice using PET. [<sup<11</sup<C]BPTES was synthesized by the reaction of an amine precursor () with [<sup<11</sup<C-carbonyl]phenylacetyl acid anhydride ([<sup<11</sup<C]<b<2</b<), which was prepared from [<sup<11</sup<C]CO<sub<2</sub< and benzyl magnesium chloride, followed by in situ treatment with isobutyl chloroformate. The decay-corrected isolated radiochemical yield of [<sup<11</sup<C]BPTES was 9.5% (based on [<sup<11</sup<C]CO<sub<2</sub<) during a synthesis time of 40 min. A PET study with [<sup<11</sup<C]BPTES showed high uptake levels of radioactivity in the liver, kidney, and small intestine of mice. [<sup<11</sup<C-carbonyl]BPTES PET glutaminase-1 (GLS1) glutaminase-1 inhibitor senescence [<sup<11</sup<C]acylation Medicine R Pharmacy and materia medica Katsushi Kumata verfasserin aut Lin Xie verfasserin aut Yusuke Kurihara verfasserin aut Masanao Ogawa verfasserin aut Tomomi Kokufuta verfasserin aut Nobuki Nengaki verfasserin aut Ming-Rong Zhang verfasserin aut In Pharmaceuticals MDPI AG, 2005 16(2023), 7, p 963 (DE-627)491437528 (DE-600)2193542-7 14248247 nnns volume:16 year:2023 number:7, p 963 https://doi.org/10.3390/ph16070963 kostenfrei https://doaj.org/article/19e9d20f8c2740e48bc14481b8ce8245 kostenfrei https://www.mdpi.com/1424-8247/16/7/963 kostenfrei https://doaj.org/toc/1424-8247 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 16 2023 7, p 963 |
spelling |
10.3390/ph16070963 doi (DE-627)DOAJ09384431X (DE-599)DOAJ19e9d20f8c2740e48bc14481b8ce8245 DE-627 ger DE-627 rakwb eng RS1-441 Yiding Zhang verfasserin aut The Glutaminase-1 Inhibitor [<sup<11</sup<C-carbony]BPTES: Synthesis and Positron Emission Tomography Study in Mice 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) is a selective inhibitor of glutaminase-1 (GLS1), consequently inhibiting glutaminolysis. BPTES is known for its potent antitumor activity and plays a significant role in senescent cell removal. In this study, we synthesized [<sup<11</sup<C-carbonyl]BPTES ([<sup<11</sup<C]BPTES) as a positron emission tomography (PET) probe for the first time and assessed its biodistribution in mice using PET. [<sup<11</sup<C]BPTES was synthesized by the reaction of an amine precursor () with [<sup<11</sup<C-carbonyl]phenylacetyl acid anhydride ([<sup<11</sup<C]<b<2</b<), which was prepared from [<sup<11</sup<C]CO<sub<2</sub< and benzyl magnesium chloride, followed by in situ treatment with isobutyl chloroformate. The decay-corrected isolated radiochemical yield of [<sup<11</sup<C]BPTES was 9.5% (based on [<sup<11</sup<C]CO<sub<2</sub<) during a synthesis time of 40 min. A PET study with [<sup<11</sup<C]BPTES showed high uptake levels of radioactivity in the liver, kidney, and small intestine of mice. [<sup<11</sup<C-carbonyl]BPTES PET glutaminase-1 (GLS1) glutaminase-1 inhibitor senescence [<sup<11</sup<C]acylation Medicine R Pharmacy and materia medica Katsushi Kumata verfasserin aut Lin Xie verfasserin aut Yusuke Kurihara verfasserin aut Masanao Ogawa verfasserin aut Tomomi Kokufuta verfasserin aut Nobuki Nengaki verfasserin aut Ming-Rong Zhang verfasserin aut In Pharmaceuticals MDPI AG, 2005 16(2023), 7, p 963 (DE-627)491437528 (DE-600)2193542-7 14248247 nnns volume:16 year:2023 number:7, p 963 https://doi.org/10.3390/ph16070963 kostenfrei https://doaj.org/article/19e9d20f8c2740e48bc14481b8ce8245 kostenfrei https://www.mdpi.com/1424-8247/16/7/963 kostenfrei https://doaj.org/toc/1424-8247 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 16 2023 7, p 963 |
allfields_unstemmed |
10.3390/ph16070963 doi (DE-627)DOAJ09384431X (DE-599)DOAJ19e9d20f8c2740e48bc14481b8ce8245 DE-627 ger DE-627 rakwb eng RS1-441 Yiding Zhang verfasserin aut The Glutaminase-1 Inhibitor [<sup<11</sup<C-carbony]BPTES: Synthesis and Positron Emission Tomography Study in Mice 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) is a selective inhibitor of glutaminase-1 (GLS1), consequently inhibiting glutaminolysis. BPTES is known for its potent antitumor activity and plays a significant role in senescent cell removal. In this study, we synthesized [<sup<11</sup<C-carbonyl]BPTES ([<sup<11</sup<C]BPTES) as a positron emission tomography (PET) probe for the first time and assessed its biodistribution in mice using PET. [<sup<11</sup<C]BPTES was synthesized by the reaction of an amine precursor () with [<sup<11</sup<C-carbonyl]phenylacetyl acid anhydride ([<sup<11</sup<C]<b<2</b<), which was prepared from [<sup<11</sup<C]CO<sub<2</sub< and benzyl magnesium chloride, followed by in situ treatment with isobutyl chloroformate. The decay-corrected isolated radiochemical yield of [<sup<11</sup<C]BPTES was 9.5% (based on [<sup<11</sup<C]CO<sub<2</sub<) during a synthesis time of 40 min. A PET study with [<sup<11</sup<C]BPTES showed high uptake levels of radioactivity in the liver, kidney, and small intestine of mice. [<sup<11</sup<C-carbonyl]BPTES PET glutaminase-1 (GLS1) glutaminase-1 inhibitor senescence [<sup<11</sup<C]acylation Medicine R Pharmacy and materia medica Katsushi Kumata verfasserin aut Lin Xie verfasserin aut Yusuke Kurihara verfasserin aut Masanao Ogawa verfasserin aut Tomomi Kokufuta verfasserin aut Nobuki Nengaki verfasserin aut Ming-Rong Zhang verfasserin aut In Pharmaceuticals MDPI AG, 2005 16(2023), 7, p 963 (DE-627)491437528 (DE-600)2193542-7 14248247 nnns volume:16 year:2023 number:7, p 963 https://doi.org/10.3390/ph16070963 kostenfrei https://doaj.org/article/19e9d20f8c2740e48bc14481b8ce8245 kostenfrei https://www.mdpi.com/1424-8247/16/7/963 kostenfrei https://doaj.org/toc/1424-8247 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 16 2023 7, p 963 |
allfieldsGer |
10.3390/ph16070963 doi (DE-627)DOAJ09384431X (DE-599)DOAJ19e9d20f8c2740e48bc14481b8ce8245 DE-627 ger DE-627 rakwb eng RS1-441 Yiding Zhang verfasserin aut The Glutaminase-1 Inhibitor [<sup<11</sup<C-carbony]BPTES: Synthesis and Positron Emission Tomography Study in Mice 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) is a selective inhibitor of glutaminase-1 (GLS1), consequently inhibiting glutaminolysis. BPTES is known for its potent antitumor activity and plays a significant role in senescent cell removal. In this study, we synthesized [<sup<11</sup<C-carbonyl]BPTES ([<sup<11</sup<C]BPTES) as a positron emission tomography (PET) probe for the first time and assessed its biodistribution in mice using PET. [<sup<11</sup<C]BPTES was synthesized by the reaction of an amine precursor () with [<sup<11</sup<C-carbonyl]phenylacetyl acid anhydride ([<sup<11</sup<C]<b<2</b<), which was prepared from [<sup<11</sup<C]CO<sub<2</sub< and benzyl magnesium chloride, followed by in situ treatment with isobutyl chloroformate. The decay-corrected isolated radiochemical yield of [<sup<11</sup<C]BPTES was 9.5% (based on [<sup<11</sup<C]CO<sub<2</sub<) during a synthesis time of 40 min. A PET study with [<sup<11</sup<C]BPTES showed high uptake levels of radioactivity in the liver, kidney, and small intestine of mice. [<sup<11</sup<C-carbonyl]BPTES PET glutaminase-1 (GLS1) glutaminase-1 inhibitor senescence [<sup<11</sup<C]acylation Medicine R Pharmacy and materia medica Katsushi Kumata verfasserin aut Lin Xie verfasserin aut Yusuke Kurihara verfasserin aut Masanao Ogawa verfasserin aut Tomomi Kokufuta verfasserin aut Nobuki Nengaki verfasserin aut Ming-Rong Zhang verfasserin aut In Pharmaceuticals MDPI AG, 2005 16(2023), 7, p 963 (DE-627)491437528 (DE-600)2193542-7 14248247 nnns volume:16 year:2023 number:7, p 963 https://doi.org/10.3390/ph16070963 kostenfrei https://doaj.org/article/19e9d20f8c2740e48bc14481b8ce8245 kostenfrei https://www.mdpi.com/1424-8247/16/7/963 kostenfrei https://doaj.org/toc/1424-8247 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 16 2023 7, p 963 |
allfieldsSound |
10.3390/ph16070963 doi (DE-627)DOAJ09384431X (DE-599)DOAJ19e9d20f8c2740e48bc14481b8ce8245 DE-627 ger DE-627 rakwb eng RS1-441 Yiding Zhang verfasserin aut The Glutaminase-1 Inhibitor [<sup<11</sup<C-carbony]BPTES: Synthesis and Positron Emission Tomography Study in Mice 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) is a selective inhibitor of glutaminase-1 (GLS1), consequently inhibiting glutaminolysis. BPTES is known for its potent antitumor activity and plays a significant role in senescent cell removal. In this study, we synthesized [<sup<11</sup<C-carbonyl]BPTES ([<sup<11</sup<C]BPTES) as a positron emission tomography (PET) probe for the first time and assessed its biodistribution in mice using PET. [<sup<11</sup<C]BPTES was synthesized by the reaction of an amine precursor () with [<sup<11</sup<C-carbonyl]phenylacetyl acid anhydride ([<sup<11</sup<C]<b<2</b<), which was prepared from [<sup<11</sup<C]CO<sub<2</sub< and benzyl magnesium chloride, followed by in situ treatment with isobutyl chloroformate. The decay-corrected isolated radiochemical yield of [<sup<11</sup<C]BPTES was 9.5% (based on [<sup<11</sup<C]CO<sub<2</sub<) during a synthesis time of 40 min. A PET study with [<sup<11</sup<C]BPTES showed high uptake levels of radioactivity in the liver, kidney, and small intestine of mice. [<sup<11</sup<C-carbonyl]BPTES PET glutaminase-1 (GLS1) glutaminase-1 inhibitor senescence [<sup<11</sup<C]acylation Medicine R Pharmacy and materia medica Katsushi Kumata verfasserin aut Lin Xie verfasserin aut Yusuke Kurihara verfasserin aut Masanao Ogawa verfasserin aut Tomomi Kokufuta verfasserin aut Nobuki Nengaki verfasserin aut Ming-Rong Zhang verfasserin aut In Pharmaceuticals MDPI AG, 2005 16(2023), 7, p 963 (DE-627)491437528 (DE-600)2193542-7 14248247 nnns volume:16 year:2023 number:7, p 963 https://doi.org/10.3390/ph16070963 kostenfrei https://doaj.org/article/19e9d20f8c2740e48bc14481b8ce8245 kostenfrei https://www.mdpi.com/1424-8247/16/7/963 kostenfrei https://doaj.org/toc/1424-8247 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 16 2023 7, p 963 |
language |
English |
source |
In Pharmaceuticals 16(2023), 7, p 963 volume:16 year:2023 number:7, p 963 |
sourceStr |
In Pharmaceuticals 16(2023), 7, p 963 volume:16 year:2023 number:7, p 963 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
[<sup<11</sup<C-carbonyl]BPTES PET glutaminase-1 (GLS1) glutaminase-1 inhibitor senescence [<sup<11</sup<C]acylation Medicine R Pharmacy and materia medica |
isfreeaccess_bool |
true |
container_title |
Pharmaceuticals |
authorswithroles_txt_mv |
Yiding Zhang @@aut@@ Katsushi Kumata @@aut@@ Lin Xie @@aut@@ Yusuke Kurihara @@aut@@ Masanao Ogawa @@aut@@ Tomomi Kokufuta @@aut@@ Nobuki Nengaki @@aut@@ Ming-Rong Zhang @@aut@@ |
publishDateDaySort_date |
2023-01-01T00:00:00Z |
hierarchy_top_id |
491437528 |
id |
DOAJ09384431X |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ09384431X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240413021510.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240413s2023 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/ph16070963</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ09384431X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ19e9d20f8c2740e48bc14481b8ce8245</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS1-441</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Yiding Zhang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The Glutaminase-1 Inhibitor [<sup<11</sup<C-carbony]BPTES: Synthesis and Positron Emission Tomography Study in Mice</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) is a selective inhibitor of glutaminase-1 (GLS1), consequently inhibiting glutaminolysis. BPTES is known for its potent antitumor activity and plays a significant role in senescent cell removal. In this study, we synthesized [<sup<11</sup<C-carbonyl]BPTES ([<sup<11</sup<C]BPTES) as a positron emission tomography (PET) probe for the first time and assessed its biodistribution in mice using PET. [<sup<11</sup<C]BPTES was synthesized by the reaction of an amine precursor () with [<sup<11</sup<C-carbonyl]phenylacetyl acid anhydride ([<sup<11</sup<C]<b<2</b<), which was prepared from [<sup<11</sup<C]CO<sub<2</sub< and benzyl magnesium chloride, followed by in situ treatment with isobutyl chloroformate. The decay-corrected isolated radiochemical yield of [<sup<11</sup<C]BPTES was 9.5% (based on [<sup<11</sup<C]CO<sub<2</sub<) during a synthesis time of 40 min. A PET study with [<sup<11</sup<C]BPTES showed high uptake levels of radioactivity in the liver, kidney, and small intestine of mice.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">[<sup<11</sup<C-carbonyl]BPTES</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">PET</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">glutaminase-1 (GLS1)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">glutaminase-1 inhibitor</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">senescence</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">[<sup<11</sup<C]acylation</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pharmacy and materia medica</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Katsushi Kumata</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Lin Xie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yusuke Kurihara</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Masanao Ogawa</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Tomomi Kokufuta</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Nobuki Nengaki</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ming-Rong Zhang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Pharmaceuticals</subfield><subfield code="d">MDPI AG, 2005</subfield><subfield code="g">16(2023), 7, p 963</subfield><subfield code="w">(DE-627)491437528</subfield><subfield code="w">(DE-600)2193542-7</subfield><subfield code="x">14248247</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:16</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:7, p 963</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/ph16070963</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/19e9d20f8c2740e48bc14481b8ce8245</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/1424-8247/16/7/963</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1424-8247</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">16</subfield><subfield code="j">2023</subfield><subfield code="e">7, p 963</subfield></datafield></record></collection>
|
callnumber-first |
R - Medicine |
author |
Yiding Zhang |
spellingShingle |
Yiding Zhang misc RS1-441 misc [<sup<11</sup<C-carbonyl]BPTES misc PET misc glutaminase-1 (GLS1) misc glutaminase-1 inhibitor misc senescence misc [<sup<11</sup<C]acylation misc Medicine misc R misc Pharmacy and materia medica The Glutaminase-1 Inhibitor [<sup<11</sup<C-carbony]BPTES: Synthesis and Positron Emission Tomography Study in Mice |
authorStr |
Yiding Zhang |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)491437528 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
RS1-441 |
illustrated |
Not Illustrated |
issn |
14248247 |
topic_title |
RS1-441 The Glutaminase-1 Inhibitor [<sup<11</sup<C-carbony]BPTES: Synthesis and Positron Emission Tomography Study in Mice [<sup<11</sup<C-carbonyl]BPTES PET glutaminase-1 (GLS1) glutaminase-1 inhibitor senescence [<sup<11</sup<C]acylation |
topic |
misc RS1-441 misc [<sup<11</sup<C-carbonyl]BPTES misc PET misc glutaminase-1 (GLS1) misc glutaminase-1 inhibitor misc senescence misc [<sup<11</sup<C]acylation misc Medicine misc R misc Pharmacy and materia medica |
topic_unstemmed |
misc RS1-441 misc [<sup<11</sup<C-carbonyl]BPTES misc PET misc glutaminase-1 (GLS1) misc glutaminase-1 inhibitor misc senescence misc [<sup<11</sup<C]acylation misc Medicine misc R misc Pharmacy and materia medica |
topic_browse |
misc RS1-441 misc [<sup<11</sup<C-carbonyl]BPTES misc PET misc glutaminase-1 (GLS1) misc glutaminase-1 inhibitor misc senescence misc [<sup<11</sup<C]acylation misc Medicine misc R misc Pharmacy and materia medica |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Pharmaceuticals |
hierarchy_parent_id |
491437528 |
hierarchy_top_title |
Pharmaceuticals |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)491437528 (DE-600)2193542-7 |
title |
The Glutaminase-1 Inhibitor [<sup<11</sup<C-carbony]BPTES: Synthesis and Positron Emission Tomography Study in Mice |
ctrlnum |
(DE-627)DOAJ09384431X (DE-599)DOAJ19e9d20f8c2740e48bc14481b8ce8245 |
title_full |
The Glutaminase-1 Inhibitor [<sup<11</sup<C-carbony]BPTES: Synthesis and Positron Emission Tomography Study in Mice |
author_sort |
Yiding Zhang |
journal |
Pharmaceuticals |
journalStr |
Pharmaceuticals |
callnumber-first-code |
R |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2023 |
contenttype_str_mv |
txt |
author_browse |
Yiding Zhang Katsushi Kumata Lin Xie Yusuke Kurihara Masanao Ogawa Tomomi Kokufuta Nobuki Nengaki Ming-Rong Zhang |
container_volume |
16 |
class |
RS1-441 |
format_se |
Elektronische Aufsätze |
author-letter |
Yiding Zhang |
doi_str_mv |
10.3390/ph16070963 |
author2-role |
verfasserin |
title_sort |
glutaminase-1 inhibitor [<sup<11</sup<c-carbony]bptes: synthesis and positron emission tomography study in mice |
callnumber |
RS1-441 |
title_auth |
The Glutaminase-1 Inhibitor [<sup<11</sup<C-carbony]BPTES: Synthesis and Positron Emission Tomography Study in Mice |
abstract |
Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) is a selective inhibitor of glutaminase-1 (GLS1), consequently inhibiting glutaminolysis. BPTES is known for its potent antitumor activity and plays a significant role in senescent cell removal. In this study, we synthesized [<sup<11</sup<C-carbonyl]BPTES ([<sup<11</sup<C]BPTES) as a positron emission tomography (PET) probe for the first time and assessed its biodistribution in mice using PET. [<sup<11</sup<C]BPTES was synthesized by the reaction of an amine precursor () with [<sup<11</sup<C-carbonyl]phenylacetyl acid anhydride ([<sup<11</sup<C]<b<2</b<), which was prepared from [<sup<11</sup<C]CO<sub<2</sub< and benzyl magnesium chloride, followed by in situ treatment with isobutyl chloroformate. The decay-corrected isolated radiochemical yield of [<sup<11</sup<C]BPTES was 9.5% (based on [<sup<11</sup<C]CO<sub<2</sub<) during a synthesis time of 40 min. A PET study with [<sup<11</sup<C]BPTES showed high uptake levels of radioactivity in the liver, kidney, and small intestine of mice. |
abstractGer |
Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) is a selective inhibitor of glutaminase-1 (GLS1), consequently inhibiting glutaminolysis. BPTES is known for its potent antitumor activity and plays a significant role in senescent cell removal. In this study, we synthesized [<sup<11</sup<C-carbonyl]BPTES ([<sup<11</sup<C]BPTES) as a positron emission tomography (PET) probe for the first time and assessed its biodistribution in mice using PET. [<sup<11</sup<C]BPTES was synthesized by the reaction of an amine precursor () with [<sup<11</sup<C-carbonyl]phenylacetyl acid anhydride ([<sup<11</sup<C]<b<2</b<), which was prepared from [<sup<11</sup<C]CO<sub<2</sub< and benzyl magnesium chloride, followed by in situ treatment with isobutyl chloroformate. The decay-corrected isolated radiochemical yield of [<sup<11</sup<C]BPTES was 9.5% (based on [<sup<11</sup<C]CO<sub<2</sub<) during a synthesis time of 40 min. A PET study with [<sup<11</sup<C]BPTES showed high uptake levels of radioactivity in the liver, kidney, and small intestine of mice. |
abstract_unstemmed |
Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) is a selective inhibitor of glutaminase-1 (GLS1), consequently inhibiting glutaminolysis. BPTES is known for its potent antitumor activity and plays a significant role in senescent cell removal. In this study, we synthesized [<sup<11</sup<C-carbonyl]BPTES ([<sup<11</sup<C]BPTES) as a positron emission tomography (PET) probe for the first time and assessed its biodistribution in mice using PET. [<sup<11</sup<C]BPTES was synthesized by the reaction of an amine precursor () with [<sup<11</sup<C-carbonyl]phenylacetyl acid anhydride ([<sup<11</sup<C]<b<2</b<), which was prepared from [<sup<11</sup<C]CO<sub<2</sub< and benzyl magnesium chloride, followed by in situ treatment with isobutyl chloroformate. The decay-corrected isolated radiochemical yield of [<sup<11</sup<C]BPTES was 9.5% (based on [<sup<11</sup<C]CO<sub<2</sub<) during a synthesis time of 40 min. A PET study with [<sup<11</sup<C]BPTES showed high uptake levels of radioactivity in the liver, kidney, and small intestine of mice. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
7, p 963 |
title_short |
The Glutaminase-1 Inhibitor [<sup<11</sup<C-carbony]BPTES: Synthesis and Positron Emission Tomography Study in Mice |
url |
https://doi.org/10.3390/ph16070963 https://doaj.org/article/19e9d20f8c2740e48bc14481b8ce8245 https://www.mdpi.com/1424-8247/16/7/963 https://doaj.org/toc/1424-8247 |
remote_bool |
true |
author2 |
Katsushi Kumata Lin Xie Yusuke Kurihara Masanao Ogawa Tomomi Kokufuta Nobuki Nengaki Ming-Rong Zhang |
author2Str |
Katsushi Kumata Lin Xie Yusuke Kurihara Masanao Ogawa Tomomi Kokufuta Nobuki Nengaki Ming-Rong Zhang |
ppnlink |
491437528 |
callnumber-subject |
RS - Pharmacy |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.3390/ph16070963 |
callnumber-a |
RS1-441 |
up_date |
2024-07-03T19:43:10.213Z |
_version_ |
1803588248762580992 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ09384431X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240413021510.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240413s2023 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/ph16070963</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ09384431X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ19e9d20f8c2740e48bc14481b8ce8245</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS1-441</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Yiding Zhang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The Glutaminase-1 Inhibitor [<sup<11</sup<C-carbony]BPTES: Synthesis and Positron Emission Tomography Study in Mice</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) is a selective inhibitor of glutaminase-1 (GLS1), consequently inhibiting glutaminolysis. BPTES is known for its potent antitumor activity and plays a significant role in senescent cell removal. In this study, we synthesized [<sup<11</sup<C-carbonyl]BPTES ([<sup<11</sup<C]BPTES) as a positron emission tomography (PET) probe for the first time and assessed its biodistribution in mice using PET. [<sup<11</sup<C]BPTES was synthesized by the reaction of an amine precursor () with [<sup<11</sup<C-carbonyl]phenylacetyl acid anhydride ([<sup<11</sup<C]<b<2</b<), which was prepared from [<sup<11</sup<C]CO<sub<2</sub< and benzyl magnesium chloride, followed by in situ treatment with isobutyl chloroformate. The decay-corrected isolated radiochemical yield of [<sup<11</sup<C]BPTES was 9.5% (based on [<sup<11</sup<C]CO<sub<2</sub<) during a synthesis time of 40 min. A PET study with [<sup<11</sup<C]BPTES showed high uptake levels of radioactivity in the liver, kidney, and small intestine of mice.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">[<sup<11</sup<C-carbonyl]BPTES</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">PET</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">glutaminase-1 (GLS1)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">glutaminase-1 inhibitor</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">senescence</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">[<sup<11</sup<C]acylation</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pharmacy and materia medica</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Katsushi Kumata</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Lin Xie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yusuke Kurihara</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Masanao Ogawa</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Tomomi Kokufuta</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Nobuki Nengaki</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ming-Rong Zhang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Pharmaceuticals</subfield><subfield code="d">MDPI AG, 2005</subfield><subfield code="g">16(2023), 7, p 963</subfield><subfield code="w">(DE-627)491437528</subfield><subfield code="w">(DE-600)2193542-7</subfield><subfield code="x">14248247</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:16</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:7, p 963</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/ph16070963</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/19e9d20f8c2740e48bc14481b8ce8245</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/1424-8247/16/7/963</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1424-8247</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">16</subfield><subfield code="j">2023</subfield><subfield code="e">7, p 963</subfield></datafield></record></collection>
|
score |
7.399024 |